Free Trial

Argent BioPharma (RGT) Competitors

GBX 16 0.00 (0.00%)
(As of 11/21/2024 ET)
No competitors for Argent BioPharma were found.

Get Argent BioPharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for RGT and its competitors with MarketBeat's FREE daily newsletter.

RGT vs. The Competition

MetricArgent BioPharmaDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£8.58M£1.16B£5.09B£1.42B
Dividend YieldN/A3.13%5.04%11.56%
P/E Ratio-66.67108.73101.481,569.60
Price / SalesN/A1,868.991,207.98219,445.82
Price / CashN/A10.0939.7133.65
Price / Book-1.452.976.932.81
Net Income-£17.53M£155.79M£118.81M£157.07M
7 Day Performance-10.36%-1.38%-1.39%-0.63%
1 Month Performance-16.27%-4.22%-3.29%3.20%
1 Year PerformanceN/A90.50%32.29%97.44%

Related Companies and Tools


This page (LON:RGT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners